INS and Alzheimer disease: In post mortem brains (i.e., cerebral cortex, hippocampus and hypothalamus), the expression levels of insulin, insulin-like growth factor (IGF) 1, and IGF1 receptors were in AD patients significantly lower than in healthy age-matched individuals [82].